OOIR: Observatory of International Research

Papers

(The H4-Index of Regulatory Toxicology and Pharmacology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Regulatory landscape of nanotechnology and nanoplastics from a global perspective	133
Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials	87
Butylated hydroxyanisole: Carcinogenic food additive to be avoided or harmless antioxidant important to protect food supply?	67
Toxicity of boric acid, borax and other boron containing compounds: A review	65
Review of regulatory reference values and background levels for heavy metals in the human diet	59
Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology	55
Can we define a level of protection for allergic consumers that everyone can accept?	47
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients	44
Occupational exposure to hexavalent chromium. Part I. Hazard assessment of non-cancer health effects	44
Occupational exposure to hexavalent chromium. Part II. Hazard assessment of carcinogenic effects	43
Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: Report of the scientific committee on health, emerging and environmental risks (SCHEER)	41
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop	41
A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment	40
Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations	34
Safe- and sustainable-by-design: The case of Smart Nanomaterials. A perspective based on a European workshop	33
Reflections on the OECD guidelines for in vitro skin absorption studies	32
The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30–31 March 2021, SCCS/1628/21	30
Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice	28
Corrigendum to “Use of an aggregate exposure model to estimate consumer exposure to fragrance ingredients in personal care and cosmetic products” [Regul. Toxicol. Pharmacol. 72 3 (2015) 673-68]	27
Towards harmonisation of testing of nanomaterials for EU regulatory requirements on chemical safety – A proposal for further actions	26
Assessment of black cumin (Nigella sativa L.) as a food ingredient and putative therapeutic agent	26
Analysis of variability in the rabbit skin irritation assay	25
Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential	25
New framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine	25
A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals	25